Centene Corp - to Redeem $500 Million of 4.25% Notes Due 2027 on August 13, 2026 - SEC Filing

Centene Corp - $568.70 Mln of 2027 Notes to Remain Outstanding After Redemption - SEC Filing

Centene to Redeem USD 500 Million of 4.25% Notes Due 2027 on Aug. 13

Centene Corp : Truist Securities Raises Target Price to $80 from $78

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), Centene (CNC) and Incyte (INCY)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC) and Dyne Therapeutics (DYN)

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Centene Director Paul J. Diaz Files Initial Beneficial Ownership Statement

Centene Falls After Flagging Bigger Drop in Medicaid Membership

NASDAQ Trade Halt Volatility Trading Pause at 09:31 Am

Sector Update: Healthcare Stocks Flat to Higher Pre-Bell Tuesday

Centene CEO Says Co is Expecting Lower Year-End Membership than Its Previous Outlook Through the Back Half of the Year - Conf. Call

U.S. Stocks on the MOVE-Sherwin-Williams, Johnson & Johnson, IQVIA

Centene Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Centene Commercial Profitability Surges on Marketplace Pricing Realignment

Centene's Medicare and Commercial Windfalls Drive Annual Guidance Increase

Centene Corp: on July 27, 2026, Committed to Accept Employees' Offers to Participate in a Voluntary Separation Program

Centene: Estimates Severance Costs of $315m-$365m for Voluntary Separation Program in 2026 - SEC Filing

Centene Shares Rise 3.7% Premarket After Co Lifts Annual Profit Forecast

Centene Appoints Cressey’s Paul Diaz to Board as Burdick Retires